(Q48307195)

10 February 2018

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Polychlorinated biphenyls induce proinflammatory cytokine release and dopaminergic dysfunction: protection in interleukin-6 knockout mice. (English)

1 reference

10 February 2018

0 references

1 reference

polychlorinated biphenyl

1 reference

based on heuristic

inferred from title

object named as

polychlorinated biphenyl

3 August 2023

author name string

Meleik Hebert Goodwill

series ordinal

1

1 reference

10 February 2018

David A Lawrence

series ordinal

2

1 reference

10 February 2018

Richard F Seegal

series ordinal

3

1 reference

10 February 2018

publication date

16 January 2007

1 reference

10 February 2018

Journal of Neuroimmunology

published in

1 reference

10 February 2018

volume

183

1 reference

10 February 2018

issue

1-2

1 reference

10 February 2018

page(s)

125-132

1 reference

10 February 2018

Synergistic action of pro-inflammatory agents: cellular and molecular aspects.

cites work

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Cytokine expression in the rat adrenal cortex

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Local neurochemicals and site-specific immune regulation in the CNS.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Cytokine effects on CNS biogenic amines

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Inflammation and dopaminergic neuronal loss in Parkinson's disease: a complex matter.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

TGFbeta1 and TGFbeta2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

PCB-induced inhibition of the vesicular monoamine transporter predicts reductions in synaptosomal dopamine content

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Interleukin-6 (IL-6)--a molecule with both beneficial and destructive potentials

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Impaired immune and acute-phase responses in interleukin-6-deficient mice.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Pathogenic role of glial cells in Parkinson's disease.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Impaired inflammatory response and increased oxidative stress and neurodegeneration after brain injury in interleukin-6-deficient mice

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Endogenous interleukin-6 plays a crucial protective role in streptococcal toxic shock syndrome via suppression of tumor necrosis factor alpha production

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Central/peripheral nervous system and immune responses

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Peripheral interleukin-6 administration increases extracellular concentrations of serotonin and the evoked release of serotonin in the rat striatum

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Cytokine activation of the HPA axis.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Polychlorinated biphenyls produce regional alterations of dopamine metabolism in rat brain.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Polychlorinated biphenyls and neurodegenerative disease mortality in an occupational cohort

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Polychlorinated biphenyl levels in the tissues of exposed and nonexposed humans

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Proinflammatory properties of coplanar PCBs: in vitro and in vivo evidence.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Impaired production of plasma interleukin-6 in patients with Parkinson's disease.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Cytokine-cytokine interactions and the brain

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Inflammation and neurodegeneration in Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Consequences and mechanisms of action of fish-borne toxicants: what we do not know and why.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Impaired resistance to the development of toxoplasmic encephalitis in interleukin-6-deficient mice

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Compromised peripheral immunity of mice injected intrastriatally with six-hydroxydopamine

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Estrogen provides neuroprotection against activated microglia-induced dopaminergic neuronal injury through both estrogen receptor-alpha and estrogen receptor-beta in microglia

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Time-course of the expression of inflammatory cytokines and matrix metalloproteinases in the striatum and mesencephalon of mice injected with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a dopaminergic neurotoxin

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Defective inflammatory response in interleukin 6-deficient mice

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Response inhibition at 8 and 9 1/2 years of age in children prenatally exposed to PCBs.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Further evidence for the depressive effects of cytokines: anhedonia and neurochemical changes

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

To be or not to be (inflamed)--is that the question in anti-inflammatory drug therapy of neurodegenerative disorders?

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Brain beta 2-microglobulin levels are elevated in the striatum in Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Role of TNF-alpha in muscularis inflammation and motility disorder in a TNBS-induced colitis model: clues from TNF-alpha-deficient mice

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JNEUROIM.2006.11.030

Identifiers

DOI

10.1016/J.JNEUROIM.2006.11.030

1 reference

10 February 2018

1 reference

10 February 2018